Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) EBITDA (2016)

Historic EBITDA for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to -$1.9 million.

  • Microbot Medical's EBITDA rose 8117.86% to -$1.9 million in Q3 2016 from the same period last year, while for Sep 2016 it was -$29.1 million, marking a year-over-year increase of 2338.02%. This contributed to the annual value of -$9.0 million for FY2020, which is 2597.71% down from last year.
  • As of Q3 2016, Microbot Medical's EBITDA stood at -$1.9 million, which was up 8117.86% from -$8.9 million recorded in Q2 2016.
  • In the past 5 years, Microbot Medical's EBITDA ranged from a high of -$1.9 million in Q3 2016 and a low of -$10.0 million during Q3 2015
  • Its 5-year average for EBITDA is -$7.3 million, with a median of -$6.8 million in 2014.
  • Per our database at Business Quant, Microbot Medical's EBITDA tumbled by 5656.09% in 2015 and then skyrocketed by 8117.86% in 2016.
  • Microbot Medical's EBITDA (Quarter) stood at -$6.2 million in 2012, then crashed by 45.53% to -$9.0 million in 2013, then fell by 8.61% to -$9.7 million in 2014, then rose by 12.64% to -$8.5 million in 2015, then surged by 77.88% to -$1.9 million in 2016.
  • Its EBITDA stands at -$1.9 million for Q3 2016, versus -$8.9 million for Q2 2016 and -$9.8 million for Q1 2016.